Presentations

Lectures. Controversial Issues in Clinical Trials: Interim Analyses, Multi-Center Trials, Crossover Designs, Combination Drug Testing, Dose Tolerance and Response Studies. Pharmaceutical Manufacturers Association Workshops for New Clinical Statisticians in the Industry. Washington, D. C., May 9-10, 1988 and Washington, D. C., March 6-7, 1989.

From Compartmentalization to Integration: Requirements of Global Drug Development. Boehringer-Ingelheim Worldwide Medical Directors' Meeting, Rudesheim, Germany, October 14-18, 1990.

Training Course in Non-Clinical Statistics. Course developer and leader. Pharmaceutical Manufacturers Association Education & Research Institute. Washington, D. C., January 9-11, 1991.

"Reengineering of the Clinical Drug Development Process," Invited paper on Total Quality Management in Drug Development, American Statistical Association Winter Conference. Atlanta, Georgia, January 6-7, 1994.

"Have You Developed the Skills That Are Necessary for Your Success?" Group Discussion, American Statistical Association Winter Conference, Raleigh, North Carolina, January 5-8, 1995.

"Interim Analysis in Clinical Trials," Corning Besselaar, Inc. Statisticians' Forum, Princeton, New Jersey, November 13, 1996.

"Have You Developed the Skills Necessary for Your Success in the Pharmaceutical Industry?" Biopharmaceuticals Section Roundtable Discussion Program, Joint Statistical Meetings, Baltimore, Maryland, August 8-12, 1999.

"What Do Statistical Consultants Really Do?" Invited presentation to graduate students of Department of Statistics at Texas A&M University, College Station, Texas, October 14, 2002.

"Using Historical Control Data in Evaluating Tumor Trends for Oncogenicity Studies." Amrik Shah and Ersen Arseven. Harvard School of Public Health, Department of Biostatistics, Colloquium 2003-2003 Series, Boston, April 24, 2003.